Intuitive Surgical, Inc. $ISRG Shares Acquired by Valley Wealth Managers Inc.

Valley Wealth Managers Inc. boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 52.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,084 shares of the medical equipment provider’s stock after purchasing an additional 1,409 shares during the quarter. Valley Wealth Managers Inc.’s holdings in Intuitive Surgical were worth $1,826,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC increased its holdings in shares of Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after acquiring an additional 731 shares during the period. Sivia Capital Partners LLC grew its position in Intuitive Surgical by 3.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after purchasing an additional 34 shares during the last quarter. Consolidated Portfolio Review Corp increased its stake in shares of Intuitive Surgical by 43.6% in the second quarter. Consolidated Portfolio Review Corp now owns 603 shares of the medical equipment provider’s stock valued at $328,000 after purchasing an additional 183 shares during the period. Pure Financial Advisors LLC raised its holdings in shares of Intuitive Surgical by 6.9% during the second quarter. Pure Financial Advisors LLC now owns 2,163 shares of the medical equipment provider’s stock valued at $1,175,000 after buying an additional 139 shares during the last quarter. Finally, Parsons Capital Management Inc. RI boosted its position in shares of Intuitive Surgical by 8.3% during the second quarter. Parsons Capital Management Inc. RI now owns 1,895 shares of the medical equipment provider’s stock worth $1,030,000 after buying an additional 145 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have weighed in on ISRG shares. Sanford C. Bernstein lifted their target price on Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. Jefferies Financial Group raised their price target on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a report on Wednesday, October 22nd. Robert W. Baird reduced their price objective on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a report on Friday, January 23rd. Royal Bank Of Canada raised their target price on shares of Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research note on Wednesday, December 17th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Monday, December 29th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $620.41.

Intuitive Surgical Trading Down 0.7%

NASDAQ:ISRG opened at $504.22 on Friday. The company has a 50-day moving average of $558.64 and a 200-day moving average of $511.63. The firm has a market cap of $180.75 billion, a price-to-earnings ratio of 63.91, a price-to-earnings-growth ratio of 3.92 and a beta of 1.67. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating the consensus estimate of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business’s quarterly revenue was up 18.8% on a year-over-year basis. During the same period in the prior year, the business earned $2.21 earnings per share. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Gary S. Guthart sold 24,500 shares of Intuitive Surgical stock in a transaction on Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total value of $12,987,450.00. Following the transaction, the director directly owned 3,694 shares in the company, valued at $1,958,189.40. The trade was a 86.90% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Mark Brosius sold 464 shares of the business’s stock in a transaction on Monday, December 15th. The stock was sold at an average price of $548.49, for a total value of $254,499.36. Following the sale, the senior vice president directly owned 131 shares in the company, valued at $71,852.19. This trade represents a 77.98% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 75,683 shares of company stock worth $42,066,425. 0.70% of the stock is owned by insiders.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.